Works matching IS 10834389 AND DT 2018 AND VI 23 AND IP 4


Results: 14
    1
    2
    3

    The “three‐in‐one” formulation of bismuth quadruple therapy for Helicobacter pylori eradication with or without probiotics supplementation: Efficacy and safety in daily clinical practice.

    Published in:
    Helicobacter, 2018, v. 23, n. 4, p. 1, doi. 10.1111/hel.12502
    By:
    • Zagari, Rocco Maurizio;
    • Romiti, Alessandra;
    • Ierardi, Enzo;
    • Gravina, Antonietta G.;
    • Panarese, Alba;
    • Grande, Giuseppe;
    • Savarino, Edoardo;
    • Maconi, Giovanni;
    • Stasi, Elisa;
    • Eusebi, Leonardo Henry;
    • Farinati, Fabio;
    • Conigliaro, Rita;
    • Bazzoli, Franco;
    • Romano, Marco
    Publication type:
    Article
    4
    5
    6

    Helicobacter pylori eradication with bismuth quadruple therapy leads to dysbiosis of gut microbiota with an increased relative abundance of Proteobacteria and decreased relative abundances of Bacteroidetes and Actinobacteria.

    Published in:
    Helicobacter, 2018, v. 23, n. 4, p. 1, doi. 10.1111/hel.12498
    By:
    • Hsu, Ping‐I;
    • Pan, Chao‐Yu;
    • Kao, John Y.;
    • Tsay, Feng‐Woei;
    • Peng, Nan‐Jing;
    • Kao, Sung‐Shuo;
    • Wang, Huay‐Min;
    • Tsai, Tzung‐Jiun;
    • Wu, Deng‐Chyang;
    • Chen, Chien‐Lin;
    • Tsai, Kuo‐Wang;
    • the Taiwan Acid‐related Disease (TARD) Study Group
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14

    Issue Information.

    Published in:
    Helicobacter, 2018, v. 23, n. 4, p. 1, doi. 10.1111/hel.12434
    Publication type:
    Article